Expression of membrane cofactor protein (MCP, CD46) in human liver diseases.
about
The dual role of complement in cancer and its implication in anti-tumor therapyA recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapyThe tumor-associated marker, PVRL4 (nectin-4), is the epithelial receptor for morbillivirusesChimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons.The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma.Measles virus for cancer therapy.Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma.Use of attenuated paramyxoviruses for cancer therapy.Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles.Advances in the design and development of oncolytic measles viruses.Oncolytic virotherapy for osteosarcoma using midkine promoter-regulated adenoviruses.Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.Hepatitis B virus X protein protects hepatoma and hepatic cells from complement-dependent cytotoxicity by up-regulation of CD46.Modification of the early gene enhancer-promoter improves the oncolytic potency of adenovirus 11.Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectorsA new group B adenovirus receptor is expressed at high levels on human stem and tumor cells.Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting.Localization of regions in CD46 that interact with adenovirus.Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobsAnalysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectorsGene Variations of Sixth Complement Component Affecting Tacrolimus Metabolism in Patients with Liver Transplantation for Hepatocellular Carcinoma.Transcellular passage of Neisseria meningitidis across a polarized respiratory epitheliumHepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack.Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer
P2860
Q26738682-EFE29FC9-CF04-41E5-9A74-E5B77B4B965EQ30959165-C4ED31D6-A963-4978-B4E2-A43A4FCBCD96Q33820699-63448FF5-DAD1-42FC-999F-BB0E4F55B67BQ33821284-B82EF7EB-005B-4580-ABED-70BA9F614EADQ33906116-8AB11CB9-EFFB-4E3A-8F3A-B74A4E5E09A8Q34313075-6944DBB6-A3C4-4F24-8E61-67252C335CCFQ36684556-0C6B5EED-DE9B-485C-B078-3B20CC5B4271Q37388577-E020DE79-74F9-4CE8-8827-6BCFF2AE878CQ37496310-D1A626B3-B36A-4E88-9C26-CCC819513342Q37810599-B0AFD0D1-38B3-4BF3-9F6B-FE8A35F2E6FAQ38315657-45E6B0DE-24A9-44B0-9931-4FFF62285F02Q38924566-81AE214E-447D-42F5-AEEC-C19C27C6D3DCQ39020219-37ECF0AF-BC9D-418C-BBD0-321BA328B560Q39107708-703F6380-5FA2-4180-9A68-D8F01C35D43DQ39197950-DD06417F-EABE-4CCA-BC3F-A7B791ACBD45Q39442539-262A856A-9AF6-461F-A20F-85BEEEE43354Q39502394-A94BA286-8C7C-4671-AAD2-CB1B881103C1Q40223632-44CD1195-E18B-421F-B91A-C4BC382FBF66Q40250421-2813DE12-1977-4CE6-B60D-1410FE789983Q40416477-55480574-F17F-4846-88BE-01E9D9D339FCQ40722127-7B66878D-D4F4-42E6-800C-046A487F24D4Q40815226-38B7B96D-B4EB-47D3-A932-5A3F88C37EBDQ41081350-A6ED83E5-94CB-4FE1-A025-A566C8572468Q42428389-E64DA140-6A49-4FD3-BE9B-4873541F9A54Q45365788-99C2C954-0956-471D-88E3-98D8DACCC9E3Q58753310-91B2C9BF-689C-4C65-B4A2-036C3EC5C341
P2860
Expression of membrane cofactor protein (MCP, CD46) in human liver diseases.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Expression of membrane cofactor protein (MCP, CD46) in human liver diseases.
@ast
Expression of membrane cofactor protein (MCP, CD46) in human liver diseases.
@en
type
label
Expression of membrane cofactor protein (MCP, CD46) in human liver diseases.
@ast
Expression of membrane cofactor protein (MCP, CD46) in human liver diseases.
@en
prefLabel
Expression of membrane cofactor protein (MCP, CD46) in human liver diseases.
@ast
Expression of membrane cofactor protein (MCP, CD46) in human liver diseases.
@en
P2093
P2860
P356
P1476
Expression of membrane cofactor protein (MCP, CD46) in human liver diseases.
@en
P2093
Ishizaki M
Kinugasa N
Kobayashi Y
Nakatsukasa H
Toshikuni N
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690604
P407
P577
1999-08-01T00:00:00Z
P5875
P6179
1011492697